Clinical Trial Update: RAPA-201 Therapy of Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating RAPA-201 for solid tumors, including small cell and non-small cell lung cancer and several head and neck cancers; currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma
• Head and Neck Cancer
• Malignant Melanoma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Solid Tumor
• Squamous Cell Carcinoma of Larynx
• Squamous Cell Carcinoma of Oral Cavity

Drugs mentioned

• RAPA-201

Snippet

Sponsor: Rapa Therapeutics LLC | Conditions: Solid Tumor, Small Cell and Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING